Literature DB >> 27252461

Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.

Jing-Wei Cheng1, Shu-Ying Yu1, Meng Xiao2, He Wang2, Timothy Kudinha3, Fanrong Kong4, Ying-Chun Xu5.   

Abstract

With molecular sequencing as a gold standard, the Vitek MS, Bruker Biotyper MS, and Vitek-2 Compact systems correctly identified 92.7%, 97.0%, and 15.2% of 164 Candida guillermondii isolates, respectively, and none of 8 C. fermentati isolates. All of the isolates showed high susceptibility to echinocandins, but some C. guilliermondii isolates showed low azole susceptibility.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27252461      PMCID： PMC4963529          DOI： 10.1128/JCM.00938-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Invasive Candidiasis.

Authors:  Bart Jan Kullberg; Maiken C Arendrup
Journal:  N Engl J Med       Date:  2015-10-08       Impact factor: 91.245

2.  Case report. Osteomyelitis caused by high resistant Candida guilliermondii.

Authors:  H J Tietz; V Czaika; W Sterry
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

Review 3.  What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.

Authors:  Vincenzo Savini; Chiara Catavitello; Daniela Onofrillo; Gioviana Masciarelli; Daniela Astolfi; Andrea Balbinot; Fabio Febbo; Claudio D'Amario; Domenico D'Antonio
Journal:  Mycoses       Date:  2010-10-29       Impact factor: 4.377

4.  A Comprehensive Evaluation of the Bruker Biotyper MS and Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems for Identification of Yeasts, Part of the National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study, 2012 to 2013.

Authors:  He Wang; Yan-Yan Fan; Timothy Kudinha; Zhi-Peng Xu; Meng Xiao; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

Review 5.  Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

Authors:  Michael Pfaller; Dionissios Neofytos; Daniel Diekema; Nkechi Azie; Herwig-Ulf Meier-Kriesche; Shun-Ping Quan; David Horn
Journal:  Diagn Microbiol Infect Dis       Date:  2012-10-25       Impact factor: 2.803

6.  Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

Authors:  M A Pfaller; D J Diekema; M Mendez; C Kibbler; P Erzsebet; S-C Chang; D L Gibbs; V A Newell
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.

Authors:  Meng Xiao; Xin Fan; Sharon C-A Chen; He Wang; Zi-Yong Sun; Kang Liao; Shu-Lan Chen; Yan Yan; Mei Kang; Zhi-Dong Hu; Yun-Zhuo Chu; Tie-Shi Hu; Yu-Xing Ni; Gui-Ling Zou; Fanrong Kong; Ying-Chun Xu
Journal:  J Antimicrob Chemother       Date:  2014-12-03       Impact factor: 5.790

8.  Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria.

Authors:  Vincenzo Savini; Chiara Catavitello; Ilaria Di Marzio; Gioviana Masciarelli; Daniela Astolfi; Andrea Balbinot; Azaira Bianco; Arianna Pompilio; Giovanni Di Bonaventura; Claudio D'Amario; Domenico D'Antonio
Journal:  Mycopathologia       Date:  2010-02-05       Impact factor: 2.574

9.  Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period.

Authors:  Javier Pemán; María Bosch; Emilia Cantón; Angel Viudes; Isidro Jarque; Micaela Gómez-García; José María García-Martínez; Miguel Gobernado
Journal:  Diagn Microbiol Infect Dis       Date:  2007-09-21       Impact factor: 2.803

Review 10.  Treatment of Candida famata bloodstream infections: case series and review of the literature.

Authors:  Nicholas D Beyda; Shen Hui Chuang; M Jahangir Alam; Dhara N Shah; Tat Ming Ng; Laurie McCaskey; Kevin W Garey
Journal:  J Antimicrob Chemother       Date:  2012-10-19       Impact factor: 5.790
View more
  8 in total

1.  Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.

Authors:  Laura Judith Marcos-Zambrano; Mireia Puig-Asensio; Felipe Pérez-García; Pilar Escribano; Carlos Sánchez-Carrillo; Oscar Zaragoza; Belén Padilla; Manuel Cuenca-Estrella; Benito Almirante; M Teresa Martín-Gómez; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

2.  Clinical Characteristics and Outcomes of Candidemia Caused by Meyerozyma guilliermondii Complex in Cancer Patients Undergoing Surgery.

Authors:  Jingjing Chen; Sufei Tian; Fushun Li; Guoquan Sun; Ke Yun; Shitong Cheng; Yunzhuo Chu
Journal:  Mycopathologia       Date:  2020-09-28       Impact factor: 2.574

3.  Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Authors:  Tatsuro Hirayama; Taiga Miyazaki; Yuka Yamagishi; Hiroshige Mikamo; Takashi Ueda; Kazuhiko Nakajima; Yoshio Takesue; Yoshitsugu Higashi; Yoshihiro Yamamoto; Muneyoshi Kimura; Hideki Araoka; Shuichi Taniguchi; Yuichi Fukuda; Yumi Matsuo; Akiko Furutani; Kohei Yamashita; Takahiro Takazono; Tomomi Saijo; Shintaro Shimamura; Kazuko Yamamoto; Yoshifumi Imamura; Koichi Izumikawa; Katsunori Yanagihara; Shigeru Kohno; Hiroshi Mukae
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

4.  Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.

Authors:  Meng Xiao; Zi-Yong Sun; Mei Kang; Da-Wen Guo; Kang Liao; Sharon C-A Chen; Fanrong Kong; Xin Fan; Jing-Wei Cheng; Xin Hou; Meng-Lan Zhou; Ying Li; Shu-Ying Yu; Jing-Jing Huang; He Wang; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

5.  Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system.

Authors:  Jing-Wei Cheng; Kang Liao; Timothy Kudinha; Shu-Ying Yu; Meng Xiao; He Wang; Fanrong Kong; Ying-Chun Xu
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

6.  Detection and Molecular Identification of Eight Candida Species in Clinical Samples by Simplex PCR.

Authors:  Eduardo García-Salazar; Gustavo Acosta-Altamirano; Paola Betancourt-Cisneros; María Del Rocío Reyes-Montes; Emmanuel Rosas-De-Paz; Esperanza Duarte-Escalante; Alma Rosa Sánchez-Conejo; Esther Ocharan Hernández; María Guadalupe Frías-De-León
Journal:  Microorganisms       Date:  2022-02-05

Review 7.  Distribution and antifungal susceptibility pattern of Candida species from mainland China: A systematic analysis.

Authors:  Hazrat Bilal; Muhammad Shafiq; Bing Hou; Rehmat Islam; Muhammad Nadeem Khan; Rahat Ullah Khan; Yuebin Zeng
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

Review 8.  Diagnosis and Treatment of Invasive Candidiasis.

Authors:  Natalia Barantsevich; Elena Barantsevich
Journal:  Antibiotics (Basel)       Date:  2022-05-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.